dydrogesterone has been researched along with Bonnevie-Ullrich Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Fukuda, Y; Ito, A; Katagiri, Y; Morita, M; Oji, A; Tamaki, Y | 1 |
Kimura, T; Kodama, M; Kodama, T; Komura, H; Nishio, Y | 1 |
Darragh, A | 1 |
3 other study(ies) available for dydrogesterone and Bonnevie-Ullrich Syndrome
Article | Year |
---|---|
DuoStim: a new option for fertility preservation for a woman with Turner syndrome.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Buserelin; Cryopreservation; Dydrogesterone; Female; Fertility Agents, Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Menotropins; Menstruation Disturbances; Mosaicism; Oocyte Retrieval; Ovarian Reserve; Ovulation Induction; Primary Ovarian Insufficiency; Turner Syndrome; Young Adult | 2020 |
Estrogen therapy initiated at an early age increases bone mineral density in Turner syndrome patients.
Topics: Absorptiometry, Photon; Adolescent; Adult; Age Factors; Bone Density; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Lumbar Vertebrae; Osteoporosis; Retrospective Studies; Turner Syndrome; Young Adult | 2012 |
The metabolism of the synthetic progestational compound Ro 4-8347.
Topics: Adipose Tissue; Adolescent; Dydrogesterone; Estriol; Ethinyl Estradiol; Feces; Female; Genitalia, Female; Humans; Menstruation; Muscles; Pregnanediol; Progestins; Skin; Steroids; Time Factors; Tritium; Turner Syndrome; Vagina | 1970 |